Last reviewed · How we verify

NCT04235855

EUS Guided Liver Biopsy - Will it Give Better Yield, More Tissue With Less Complication?

Completed NA Last updated 4 January 2022
What this trial tests

NA trial testing Endoscopic USG guided Liver biopsy in NAFLD in 50 participants. Completed in 1 January 2022.

Timeline
31 October 2019
Primary endpoint
1 January 2022
1 January 2022

Quick facts

Lead sponsorAsian Institute of Gastroenterology, India
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingsingle
Primary purposediagnostic
Enrollment50
Start date31 October 2019
Primary completion1 January 2022
Estimated completion1 January 2022
Sites1 location across India

Drugs / interventions tested

Conditions studied

Sponsor

Asian Institute of Gastroenterology, India

Who can join

Adults 18 to 70, any sex, with NAFLD or Alcoholic Hepatitis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Liver biopsy would be done by Endoscopic Ultrasound using Acquire needle.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

  1. EUS-guided left lobe liver biopsy: Safer modality with similar diagnostic yield as right lobe: a pilot study.
    Sharma M, Lakhtakia S, Jagtap N, Sekaran A, et al · · 2023 · cited 7× · PMID 36845273 · DOI 10.1055/a-1978-6652
  2. Liver Biopsy in Patients With Alcohol-Associated Liver Disease With Acute-on-Chronic Liver Failure.
    Jophlin L, Singal AK. · · 2022 · cited 6× · PMID 35535109 · DOI 10.1016/j.jceh.2021.08.009

Verify or expand the search:

Other recruiting trials for NAFLD

Currently open trials in the same condition.

Other Asian Institute of Gastroenterology, India trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04235855.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing